CPT® Code 83893

Deleted

1. Indications

The procedure associated with CPT® Code 83893 is indicated for various clinical scenarios, including:

• Genetic Mutation Detection Molecular diagnostics are performed to identify genetic mutations that may suggest the presence of certain diseases, even when patients do not exhibit symptoms.
• Monitoring Disease States These tests can be utilized to monitor ongoing disease conditions, providing valuable information regarding the progression or response to treatment.
• Screening for Genetic Carriers The procedure is also indicated for screening individuals who may be carriers of genetic diseases, which is essential for family planning and preventive healthcare.
• Assessing Predisposition to Conditions Molecular diagnostics can help identify individuals who are genetically predisposed to certain health conditions, allowing for early intervention and preventive measures.

2. Procedure

The procedure for CPT® Code 83893 involves several key steps, which are detailed as follows:

• Nucleic Acid Preparation The first step in the dot/slot blot production process is the preparation of nucleic acids. This may involve the extraction of nucleic acids from biological samples, which can include blood, tissue, or other bodily fluids. The preparation can consist of undigested nucleic acids, digestates, or specially modified samples, such as newly synthesized oligonucleotides, depending on the specific requirements of the diagnostic test.
• Dot/Slot Blot Technique Following the preparation, the dot/slot blot technique is employed. This method involves applying the prepared nucleic acid samples onto a solid support, such as a membrane. The samples are then allowed to adhere to the membrane, creating distinct dots or slots that represent the nucleic acid preparations. This step is crucial for the subsequent detection and analysis of the proteins associated with the nucleic acids.
• Detection and Analysis After the samples have been applied to the membrane, various detection methods may be utilized to analyze the proteins present in the extracted nucleic acid samples. This can involve the use of specific probes or antibodies that bind to target proteins, allowing for visualization and quantification. The results obtained from this analysis provide critical information regarding the presence of genetic mutations or other relevant biomarkers.

3. Post-Procedure

Post-procedure care for patients undergoing molecular diagnostics involving CPT® Code 83893 typically includes monitoring for any immediate reactions to the sample collection process. While the procedure itself is generally non-invasive, it is essential to ensure that the samples are handled and processed correctly to maintain the integrity of the results. Patients may receive guidance on follow-up appointments to discuss the findings of the molecular diagnostic tests, as well as any necessary next steps based on the results. Additionally, healthcare providers may recommend further testing or preventive measures depending on the outcomes of the analysis.